Sustained response to lenvatinib and pembrolizumab in two patients with KRAS-mutated endometrial mesonephric-like adenocarcinoma

Sustained response to lenvatinib and pembrolizumab in two patients with KRAS-mutated endometrial mesonephric-like adenocarcinoma

Bibliographic Details
Main Authors:	Sherry Shen, Maria M. Rubinstein, Kay J. Park, Jason A. Konner, Vicky Makker
Format:	Article
Language:	English
Published:	Elsevier 2021-08-01
Series:	Gynecologic Oncology Reports
Subjects:	Endometrial Mesonephric Mesonephric-like Lenvatinib Pembrolizumab KRAS
Online Access:	http://www.sciencedirect.com/science/article/pii/S235257892100148X

Similar Items

The similarities and differences between mesonephric carcinoma and mesonephric-like carcinoma: Two cases
by: Amita Kulkarni, et al.
Published: (2021-08-01)

Molecular profiling of mesonephric and mesonephric-like carcinomas of cervical, endometrial and ovarian origin
by: Douglas I. Lin, et al.
Published: (2020-11-01)

Mesonephric adenocarcinoma of the cervix: a case report with a three-year follow-up, lung metastases, and next-generation sequencing analysis
by: Nelson Montalvo, et al.
Published: (2019-07-01)

Mesonephric-like Differentiation of Endometrial Endometrioid Carcinoma: Clinicopathological and Molecular Characteristics Distinct from Those of Uterine Mesonephric-like Adenocarcinoma
by: Sujin Park, et al.
Published: (2021-08-01)

Mesonephric adenocarcinoma of the cervix: Case report and literature review
by: A. Dierickx, et al.
Published: (2016-08-01)

Mesonephric-Like Carcinosarcoma of the Ovary Associated with Low-Grade Serous Carcinoma: A Case Report
by: Antonio d’Amati, et al.
Published: (2021-05-01)

Mesonephric-like adenocarcinoma of the ovary with co-existent endometriosis: A case report and review of the literature
by: Kieran Seay, et al.
Published: (2020-11-01)

Coexistence of endometrial mesonephric-like adenocarcinoma and endometrioid carcinoma suggests a Müllerian duct lineage: a case report
by: Mitsutake Yano, et al.
Published: (2019-06-01)

Mesonephric adenocarcinoma (endometrioid type) of endocervix with diffuse mesonephric hyperplasia involving cervical wall and myometrium: An unusual case report
by: Santosh Menon, et al.
Published: (2013-01-01)

Mesonephric-Like Adenocarcinoma of the Endometrium: Diagnostic Advances to Spot This Wolf in Sheep’s Clothing. A Review of the Literature
by: Ellen Deolet, et al.
Published: (2021-02-01)

Mesonephric adenocarcinoma of the uterine corpus with intracystic growth completely confined to the myometrium: a case report and literature review
by: Hiroka Ando, et al.
Published: (2017-08-01)

Ovarian mesonephric-like adenocarcinoma arising in serous borderline tumor: a case report with complex morphological and molecular analysis
by: Pavel Dundr, et al.
Published: (2020-07-01)

Mesonephric adenoma in remnant ureteric stump: A rare entity
by: Kamal Jeet Singh
Published: (2011-01-01)

Unilateral Complete Agenesis of Mesonephric Duct Derivatives in an 82-year-Old Male Cadaver: Embryology, Anatomy and Clinical Considerations
by: David G. Darcy, et al.
Published: (2017-11-01)

Lenvatinib and pembrolizumab in patients with advanced uterine cancer
by: A. G. Kedrova, et al.
Published: (2021-01-01)

Mesonephric Adenocarcinoma of the Uterine Fundus Exhibiting High <sup>18</sup>F-FDG Uptake
by: Hyung Kyung Kim, et al.
Published: (2020-09-01)

Serous Carcinoma of the Endometrium with Mesonephric-Like Differentiation Initially Misdiagnosed as Uterine Mesonephric-Like Adenocarcinoma: A Case Report with Emphasis on the Immunostaining and the Identification of Splice Site <i>TP53</i> Mutation
by: Sangjoon Choi, et al.
Published: (2021-04-01)

Mesonephric remnant (paroophoron) presenting as a congenital lumbar sinus in a child
by: Saurabh Garge, et al.
Published: (2020-01-01)

Lenvatinib plus pembrolizumab in patients with advanced or recurrent uterine carcinosarcoma
by: Jonathan T. Hunt, et al.
Published: (2021-08-01)

Complete response to the combination of Lenvatinib and Pembrolizumab in an advanced hepatocellular carcinoma patient: a case report
by: Zhaonan Liu, et al.
Published: (2019-11-01)

A Triad of Unilateral Renal Dysgenesis with Ipsilateral Seminal Vesical and Ejaculatory Duct Obstruction: An Uncommon Urogenital Congenital Anomaly, Zinner Syndrome—A Case Report
by: Rajani Gorantla, et al.
Published: (2021-09-01)

Zinner syndrome: A unique triad of mesonephric duct abnormalities as an unusual cause of urinary symptoms in late adolescence
by: Nitin P Ghonge, et al.
Published: (2010-01-01)

Uterine cervical mesonephric hyperplasia with focal cystic change masquerading clinicopathologically as lobular endocervical glandular hyperplasia to malignancy
by: Ken-ichi Mizutani, et al.
Published: (2018-06-01)

COMBINATION OF LENVATINIB AND PEMBROLISUMAB IN THE TREATMENT OF ADVANCED ENDOMETRIAL CANCER: A CASE REPORT
by: O. N. Churuksaeva, et al.
Published: (2021-03-01)

Female Adnexal Tumour of Wolffian Origin: A Rare Case Report
by: Soumit Dey, et al.
Published: (2021-07-01)

YRDC Mediates the Resistance of Lenvatinib in Hepatocarcinoma Cells via Modulating the Translation of KRAS
by: Jun Guo, et al.
Published: (2021-10-01)

Huge uterine-cervical diverticulum mimicking as a cyst
by: S Chufal, et al.
Published: (2012-01-01)

Incidental detection of Zinner syndrome in a patient with nonseminomatous germ cell tumor of testis
by: Jeevitesh Khoda, et al.
Published: (2020-01-01)

Paradidymis – Fact/Fiction and its Significance
by: M. Raghavendran, et al.
Published: (2016-07-01)

The safety and efficacy of lenvatinib combined with immune checkpoint inhibitors therapy for advanced hepatocellular carcinoma
by: Yun Wang, et al.
Published: (2020-12-01)

Hepatogonadal fusion in cryptorchidism
by: Montasser El-koutby, et al.
Published: (2018-07-01)

Malignant Female Adnexal Tumor of Probable Wolffian Origin (FATWO): A case report and review for the literature
by: Risha Sinha, et al.
Published: (2021-05-01)

Case Report: Significant Response to the Combination of Lenvatinib and Immune Checkpoint Inhibitor in a Patient With Heavily Pretreated Metastatic Triple Negative Breast Cancer
by: Jin Sun Lee, et al.
Published: (2021-01-01)

Rapid Response to the Combination of Lenvatinib and Pembrolizumab in Patients with Advanced Carcinomas (Lung Adenocarcinoma and Malignant Pleural Mesothelioma)
by: Walid Shalata, et al.
Published: (2021-07-01)

Durable complete remission after Pembrolizumab in pretreated advanced endometrial cancer: A case report
by: Bacigalupo, L., et al.
Published: (2022)

Uterine Cervix-Benign Histomorphological Spectrum
by: Sunila Basnet, et al.
Published: (2018-06-01)

Lenvatinib-Transarterial Chemoembolization Sequential Therapy as an Effective Treatment at Progression during Lenvatinib Therapy for Advanced Hepatocellular Carcinoma
by: Yusuke Kawamura, et al.
Published: (2020-10-01)

Posttreatment after Lenvatinib in Patients with Advanced Hepatocellular Carcinoma
by: Keisuke Koroki, et al.
Published: (2021-04-01)

Targeting KRAS in Solid Tumors: Current Challenges and Future Opportunities of Novel KRAS Inhibitors
by: Alice Indini, et al.
Published: (2021-05-01)

Shunt occlusion prior to lenvatinib administration prevents hepatic encephalopathy and hyperammonemia
by: Ai Kuwahara, et al.
Published: (2020-08-01)